Cargando…
Overcoming the growth–infectivity trade‐off in a bacteriophage slows bacterial resistance evolution
The use of lytic bacteriophages for treating harmful bacteria (phage therapy) is faced with the challenge of bacterial resistance evolution. Phage strains with certain traits, for example, rapid growth and relatively broad infectivity ranges, may enjoy an advantage in slowing bacterial resistance ev...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372119/ https://www.ncbi.nlm.nih.gov/pubmed/34429748 http://dx.doi.org/10.1111/eva.13260 |